FDA Clearance Tracker · P890055-S013
MODEL 3000 SERIES IMPLANTABLE INFUSION PUMPS
Last checked: Nov 20, 2026Latest source record: Oct 18, 2002 (this decision)Source: openFDAMethods & limitations
Decided
Oct 18, 2002
Approved
Time to decision
499 days
Received Jun 6, 2001. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track
Device class
Class III
The decision
- FDA number
- P890055-S013
- Device name
- MODEL 3000 SERIES IMPLANTABLE INFUSION PUMPS
- Applicant
- Intera Oncology
- Applicant location
- Newton, MA
- Received
- Jun 6, 2001
- Decided
- Oct 18, 2002
- Decision
- Approved
- Supplement type
- Normal 180 Day Track
- Reason for supplement
- Labeling Change - Indications/instructions/shelf life/tradename
- Original approval
- P890055
Device type
- Device class
- Class III
- Specialty
- Hospital Medicine & Nursing
FDA's approval statement
As written in FDA's record.
APPROVAL FOR THE INDICATIONS FOR USE TO INCLUDE GLYCERIN INJECTION AS AN INFUSATE FOR USE WITH PATIENTS WHO ARE RECEIVING CONTINUOUS HEPATIC ARTERIAL FUDR CHEMOTHERAPY WITH THE ARROW INTERNATIONAL MODEL 3000 SERIES OF IMPLANTABLE INFUSION PUMPS TO KEEP THE CATHETER PATENT OR TO EXTEND THE REFILL INTERVAL FOR PATIENTS WHO REQUIRE THERAPY OR WITHDRAWAL.
Source documents
Other decisions for Intera Oncology
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- Intera Refill Kit510(k)
K213823 · Decided Mar 16, 2022 · 98 days after receipt
Device type: Non-Coring (Huber) Needle (PTI) · Hospital Medicine & Nursing
1 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.